A Nanobody of PEDV S1 Protein: Screening and Expression in Escherichia coli DOI Creative Commons
Zhipeng Hao, Xufeng Dong,

Zhong-tao Zhang

et al.

Biomolecules, Journal Year: 2024, Volume and Issue: 14(9), P. 1116 - 1116

Published: Sept. 4, 2024

Porcine epidemic diarrhea virus (PEDV) has caused significant economic losses to the pig farming industry in various countries for a long time. Currently, there are no highly effective preventive or control measures available. Research into pathogenic mechanism of PEDV shown that it primarily causes infection by binding S protein CD13 (APN) receptor on membrane porcine intestinal epithelial cells. The S1 region contains three neutralization epitopes and multiple receptor-binding domains, which closely related viral antigenicity ad-sorption invasion. Nanobodies type single-domain antibody have been discovered recent years. They can be expressed large scale through prokaryotic expression systems, makes them cost-effective, stable, less immunogenic. This study used phage display library nanobodies against protein. After rounds selection enrichment, DNA sequence specific nanobody S1Nb1 was successfully obtained. To obtain soluble S1Nb1, its inserted vector Pcold solubility-enhancing SUMO tag added. resulting recombinant vector, Pcold-SUMO-S1Nb1, then transformed

Language: Английский

Albumin binding improves nanobody pharmacokinetics for dual-modality PET/NIRF imaging of CEACAM5 in colorectal cancer models DOI Open Access
Wenyu Song, Weijun Wei, Xiaoli Lan

et al.

European Journal of Nuclear Medicine and Molecular Imaging, Journal Year: 2023, Volume and Issue: 50(9), P. 2591 - 2594

Published: May 16, 2023

Language: Английский

Citations

7

COVID-19 impedimetric biosensor based on polypyrrole nanotubes, nickel hydroxide and VHH antibody fragment: specific, sensitive, and rapid viral detection in saliva samples DOI
Ana Patricia dos Santos, A.P. Macedo de Souza Brandão, Bruna M. Hryniewicz

et al.

Materials Today Chemistry, Journal Year: 2023, Volume and Issue: 30, P. 101597 - 101597

Published: June 1, 2023

Language: Английский

Citations

7

Small Antibodies with Big Applications: Nanobody-Based Cancer Diagnostics and Therapeutics DOI Open Access
Qian Zhang, Nan Zhang, Han Xiao

et al.

Cancers, Journal Year: 2023, Volume and Issue: 15(23), P. 5639 - 5639

Published: Nov. 29, 2023

Monoclonal antibodies (mAbs) have exhibited substantial potential as targeted therapeutics in cancer treatment due to their precise antigen-binding specificity. Despite success tumor-targeted therapies, effectiveness is hindered by large size and limited tissue permeability. Camelid-derived single-domain antibodies, also known nanobodies, represent the smallest naturally occurring antibody fragments. Nanobodies offer distinct advantages over traditional mAbs, including smaller size, high stability, lower manufacturing costs, deeper penetration capabilities. They demonstrated significant roles both diagnostic therapeutic tools research are considered next generation of drugs. In this review, our objective provide readers with insights into development various applications nanobodies field treatment, along an exploration challenges strategies for prospective clinical trials.

Language: Английский

Citations

7

The role of CD8 PET imaging in guiding cancer immunotherapy DOI Creative Commons
Jiani Zhang, Bulin Du, Yuxiang Wang

et al.

Frontiers in Immunology, Journal Year: 2024, Volume and Issue: 15

Published: July 12, 2024

Currently, immunotherapy is being widely used for treating cancers. However, the significant heterogeneity in patient responses a major challenge its successful application. CD8-positive T cells (CD8 + cells) play critical role immunotherapy. Both their infiltration and functional status tumors contribute to treatment outcomes. Therefore, accurate monitoring of CD8 cells, potential biomarker, may improve therapeutic strategy. Positron emission tomography (PET) an optimal option which can provide molecular imaging with enhanced specificity. This review summarizes mechanism action immunotherapy, highlights recent advancements PET-based tracers that visualize discusses clinical applications elucidate cancer

Language: Английский

Citations

1

A Nanobody of PEDV S1 Protein: Screening and Expression in Escherichia coli DOI Creative Commons
Zhipeng Hao, Xufeng Dong,

Zhong-tao Zhang

et al.

Biomolecules, Journal Year: 2024, Volume and Issue: 14(9), P. 1116 - 1116

Published: Sept. 4, 2024

Porcine epidemic diarrhea virus (PEDV) has caused significant economic losses to the pig farming industry in various countries for a long time. Currently, there are no highly effective preventive or control measures available. Research into pathogenic mechanism of PEDV shown that it primarily causes infection by binding S protein CD13 (APN) receptor on membrane porcine intestinal epithelial cells. The S1 region contains three neutralization epitopes and multiple receptor-binding domains, which closely related viral antigenicity ad-sorption invasion. Nanobodies type single-domain antibody have been discovered recent years. They can be expressed large scale through prokaryotic expression systems, makes them cost-effective, stable, less immunogenic. This study used phage display library nanobodies against protein. After rounds selection enrichment, DNA sequence specific nanobody S1Nb1 was successfully obtained. To obtain soluble S1Nb1, its inserted vector Pcold solubility-enhancing SUMO tag added. resulting recombinant vector, Pcold-SUMO-S1Nb1, then transformed

Language: Английский

Citations

1